The online RE (ACT) Community gets out of phase beta and is fully operational. Several crowdfunding projects are active.
#RAREvolution campaign ongoing.
Launch of the international program “#RAREvolution – Stand Up for Scientific Research on Rare Diseases” (to support scientific research on rare and orphan diseases). We continue the development of the “RE(ACT) Initiative” which aims to support long-term research through tools facilitating knowledge sharing, exchange of good practices, collaboration and crowdfunding for researchers. We integrate in the program advocacy and awareness raising activities for scientific research.
Start of the “RE (ACT) Initiative”, a program that aims to support long-term research through tools facilitating knowledge sharing, exchange of good practices, collaboration and crowdfunding. The initiative’s online platform “RE(ACT) Community” facilitates continuous collaboration between researchers, information gathering, crowdfunding and communication between patients and researchers. The “RE(ACT) Initiative” also includes an international scientific congress on rare diseases, the “RE(ACT) Congress”.
The beginning of the “RE (ACT) Congresses”, a series of conferences held every two years, bringing together researchers from around the world working on rare and orphan diseases.
Funding of a project on sleep disorders and narcolepsy, at the University of Lausanne, Switzerland. The aim of the project was to generate induced pluripotent stem cells (iPSC) from mice and human fibroblasts to investigate the neurobiology of hypocretin neurons and to demonstrate that cell therapy can be used in cases of narcolepsy, a chronic sleep disorder.
Funding of a research project at the Harvard Medical School on atypical Rett Syndrome (central nervous system development disorder with convulsions in the first months of life). The aim of the project was to better understand the implication of the CDKL5 gene and to test several molecules to reduce drug-resistant epileptic seizures in these young children.
Support of a research project at the Pediatric Surgery Department of the Children’s Hospital of Geneva (thanks to the generous gift of AEMO – Association Enfance et Maladie Orphelines). The aim of the project was to find an alternative to liver transplantation in small children in the case of rare metabolic diseases. The results have opened the way to new clinical studies for the treatment of hereditary metabolic diseases of the liver.